 | • レポートコード：B-GIR09D4220 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、原発性胆管胆管炎治療の世界市場について調べ、まとめました。種類別セグメントは、ウルソデオキシコール酸（UDCA）、オベチコール酸（オカリバ）等、用途別セグメントは、病院、診療所、その他等に区分しました。原発性胆管胆管炎治療の世界市場概観、企業動向、企業別原発性胆管胆管炎治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・原発性胆管胆管炎治療の市場概観 ・原発性胆管胆管炎治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・原発性胆管胆管炎治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・原発性胆管胆管炎治療の世界市場規模 ・原発性胆管胆管炎治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・原発性胆管胆管炎治療のアメリカ市場規模推移 ・原発性胆管胆管炎治療のカナダ市場規模推移 ・原発性胆管胆管炎治療のメキシコ市場規模推移 ・原発性胆管胆管炎治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・原発性胆管胆管炎治療のドイツ市場規模推移 ・原発性胆管胆管炎治療のイギリス市場規模推移 ・原発性胆管胆管炎治療のロシア市場規模推移 ・原発性胆管胆管炎治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・原発性胆管胆管炎治療の日本市場規模推移 ・原発性胆管胆管炎治療の中国市場規模推移 ・原発性胆管胆管炎治療の韓国市場規模推移 ・原発性胆管胆管炎治療のインド市場規模推移 ・原発性胆管胆管炎治療の東南アジア市場規模推移 ・原発性胆管胆管炎治療の南米市場分析（ブラジル、アルゼンチン等） ・原発性胆管胆管炎治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・原発性胆管胆管炎治療の種類別分析/販売量、売上、市場シェア（ウルソデオキシコール酸（UDCA）、オベチコール酸（オカリバ）） ・原発性胆管胆管炎治療の用途別分析/市場規模（病院、診療所、その他） ・原発性胆管胆管炎治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・原発性胆管胆管炎治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver. It results from a slow, progressive destruction of the small bile ducts of the liver, causing bile and other toxins to build up in the liver, a condition called cholestasis. There’s no cure for primary biliary cholangitis, but medications are available to help slow the progression of the disease and prevent complications. Options include: Ursodeoxycholic acid (UDCA) and Obeticholic acid (Ocaliva).
Scope of the Report:
The global Primary Biliary Cholangitis Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Primary Biliary Cholangitis Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Primary Biliary Cholangitis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Primary Biliary Cholangitis Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis
Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Teva Pharmaceutical
Retrophin
Lumena Pharmaceuticals
Intercept Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ursodeoxycholic Acid (UDCA)
Obeticholic Acid (Ocaliva)
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
Table of Contents
1 Primary Biliary Cholangitis Treatment Market Overview
1.1 Product Overview and Scope of Primary Biliary Cholangitis Treatment
1.2 Classification of Primary Biliary Cholangitis Treatment by Types
1.2.1 Global Primary Biliary Cholangitis Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Primary Biliary Cholangitis Treatment Revenue Market Share by Types in 2018
1.2.3 Ursodeoxycholic Acid (UDCA)
1.2.4 Obeticholic Acid (Ocaliva)
1.3 Global Primary Biliary Cholangitis Treatment Market by Application
1.3.1 Global Primary Biliary Cholangitis Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Primary Biliary Cholangitis Treatment Market by Regions
1.4.1 Global Primary Biliary Cholangitis Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Primary Biliary Cholangitis Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Primary Biliary Cholangitis Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Primary Biliary Cholangitis Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Primary Biliary Cholangitis Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Primary Biliary Cholangitis Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva Pharmaceutical
2.5.1 Business Overview
2.5.2 Primary Biliary Cholangitis Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceutical Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Retrophin
2.6.1 Business Overview
2.6.2 Primary Biliary Cholangitis Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Retrophin Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Lumena Pharmaceuticals
2.7.1 Business Overview
2.7.2 Primary Biliary Cholangitis Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Intercept Pharmaceuticals
2.8.1 Business Overview
2.8.2 Primary Biliary Cholangitis Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Primary Biliary Cholangitis Treatment Market Competition, by Players
3.1 Global Primary Biliary Cholangitis Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Primary Biliary Cholangitis Treatment Players Market Share
3.2.2 Top 10 Primary Biliary Cholangitis Treatment Players Market Share
3.3 Market Competition Trend
4 Global Primary Biliary Cholangitis Treatment Market Size by Regions
4.1 Global Primary Biliary Cholangitis Treatment Revenue and Market Share by Regions
4.2 North America Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
5 North America Primary Biliary Cholangitis Treatment Revenue by Countries
5.1 North America Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
5.2 USA Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
6 Europe Primary Biliary Cholangitis Treatment Revenue by Countries
6.1 Europe Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
6.2 Germany Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
6.4 France Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Primary Biliary Cholangitis Treatment Revenue by Countries
7.1 Asia-Pacific Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
7.2 China Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
7.5 India Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
8 South America Primary Biliary Cholangitis Treatment Revenue by Countries
8.1 South America Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
8.2 Brazil Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Primary Biliary Cholangitis Treatment by Countries
9.1 Middle East and Africa Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
10 Global Primary Biliary Cholangitis Treatment Market Segment by Type
10.1 Global Primary Biliary Cholangitis Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Primary Biliary Cholangitis Treatment Market Forecast by Type (2019-2024)
10.3 Ursodeoxycholic Acid (UDCA) Revenue Growth Rate (2014-2024)
10.4 Obeticholic Acid (Ocaliva) Revenue Growth Rate (2014-2024)
11 Global Primary Biliary Cholangitis Treatment Market Segment by Application
11.1 Global Primary Biliary Cholangitis Treatment Revenue Market Share by Application (2014-2019)
11.2 Primary Biliary Cholangitis Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Primary Biliary Cholangitis Treatment Market Size Forecast (2019-2024)
12.1 Global Primary Biliary Cholangitis Treatment Market Size Forecast (2019-2024)
12.2 Global Primary Biliary Cholangitis Treatment Market Forecast by Regions (2019-2024)
12.3 North America Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
12.6 South America Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Primary Biliary Cholangitis Treatment Picture
Table Product Specifications of Primary Biliary Cholangitis Treatment
Table Global Primary Biliary Cholangitis Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Primary Biliary Cholangitis Treatment Revenue Market Share by Types in 2018
Figure Ursodeoxycholic Acid (UDCA) Picture
Figure Obeticholic Acid (Ocaliva) Picture
Table Global Primary Biliary Cholangitis Treatment Revenue (Million USD) by Application (2014-2024)
Figure Primary Biliary Cholangitis Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Primary Biliary Cholangitis Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Primary Biliary Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Primary Biliary Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Primary Biliary Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Primary Biliary Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Primary Biliary Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Primary Biliary Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Primary Biliary Cholangitis Treatment Type and Applications
Table Novartis Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Type and Applications
Table Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Primary Biliary Cholangitis Treatment Type and Applications
Table Pfizer Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Primary Biliary Cholangitis Treatment Type and Applications
Table GlaxoSmithKline Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Primary Biliary Cholangitis Treatment Type and Applications
Table Teva Pharmaceutical Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Retrophin Basic Information, Manufacturing Base and Competitors
Table Retrophin Primary Biliary Cholangitis Treatment Type and Applications
Table Retrophin Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Lumena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Type and Applications
Table Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Type and Applications
Table Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Primary Biliary Cholangitis Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Primary Biliary Cholangitis Treatment Revenue Share by Players (2014-2019)
Figure Global Primary Biliary Cholangitis Treatment Revenue Share by Players in 2017
Figure Global Primary Biliary Cholangitis Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Primary Biliary Cholangitis Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Primary Biliary Cholangitis Treatment Revenue Market Share in 2018
Figure Global Primary Biliary Cholangitis Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Primary Biliary Cholangitis Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Primary Biliary Cholangitis Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Primary Biliary Cholangitis Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Primary Biliary Cholangitis Treatment Revenue Market Share by Regions in 2018
Figure North America Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure South America Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Table North America Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
Table North America Primary Biliary Cholangitis Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Primary Biliary Cholangitis Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Primary Biliary Cholangitis Treatment Revenue Market Share by Countries in 2018
Figure USA Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Table Europe Primary Biliary Cholangitis Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Primary Biliary Cholangitis Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Primary Biliary Cholangitis Treatment Revenue Market Share by Countries in 2018
Figure Germany Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure UK Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure France Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Primary Biliary Cholangitis Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Primary Biliary Cholangitis Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Primary Biliary Cholangitis Treatment Revenue Market Share by Countries in 2018
Figure China Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure India Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Table South America Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
Table South America Primary Biliary Cholangitis Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Primary Biliary Cholangitis Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Primary Biliary Cholangitis Treatment Revenue Market Share by Countries in 2018
Figure Brazil Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Primary Biliary Cholangitis Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Primary Biliary Cholangitis Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Primary Biliary Cholangitis Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Primary Biliary Cholangitis Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
Table Global Primary Biliary Cholangitis Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Primary Biliary Cholangitis Treatment Revenue Share by Type (2014-2019)
Figure Global Primary Biliary Cholangitis Treatment Revenue Share by Type (2014-2019)
Figure Global Primary Biliary Cholangitis Treatment Revenue Share by Type in 2019
Table Global Primary Biliary Cholangitis Treatment Revenue Forecast by Type (2019-2024)
Figure Global Primary Biliary Cholangitis Treatment Market Share Forecast by Type (2019-2024)
Figure Global Ursodeoxycholic Acid (UDCA) Revenue Growth Rate (2014-2019)
Figure Global Obeticholic Acid (Ocaliva) Revenue Growth Rate (2014-2019)
Table Global Primary Biliary Cholangitis Treatment Revenue by Application (2014-2019)
Table Global Primary Biliary Cholangitis Treatment Revenue Share by Application (2014-2019)
Figure Global Primary Biliary Cholangitis Treatment Revenue Share by Application (2014-2019)
Figure Global Primary Biliary Cholangitis Treatment Revenue Share by Application in 2019
Table Global Primary Biliary Cholangitis Treatment Revenue Forecast by Application (2019-2024)
Figure Global Primary Biliary Cholangitis Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Primary Biliary Cholangitis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Primary Biliary Cholangitis Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Primary Biliary Cholangitis Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
Figure Europe Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
Figure South America Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
初代細胞培養市場：世界及び中国市場分析・予測（～2024年） Primary Cell Media Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Primary Cell Media industry with a focus on the Chinese market. The report provides key statistics on the market status of the Primary Cell Media manufacturers…- 一次リチウム電池市場：世界及び中国市場分析・予測（～2024年） Primary Lithium Battery Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Primary Lithium Battery industry with a focus on the Chinese market. The report provides key statistics on the market status of the Primary Lithium Batter…
- 一次食品加工機械（PFPM）市場：世界及び中国市場分析・予測（～2024年） Primary Food Processing Machinery (PFPM) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Primary Food Processing Machinery (PFPM) industry with a focus on the Chinese market. The report provides key statistics on the market st…
- 世界のウルソデオキシコール酸製剤市場予測（～2024年） Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. Scope of the Report: In North America, Epic Pharma is leading manufactu…
- 世界の腱炎治療市場予測（～2024年） Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons. Scope of the Report: The global Tendinitis Treatment market is valued at …